CTLA-4 blockade: therapeutic potential in cancer treatments

Por Tarhini, Ahmad A, Iqbal, Fatima
Publicado em 2010

Anticancer Cytokines: Biology and Clinical Effects of IFN-α2, IL-2, IL-15, IL-21, and IL-12

Por Floros, Theofanis, Tarhini, Ahmad A.
Publicado no Semin Oncol (2015)

Clinical and Immunologic Basis of Interferon Therapy in Melanoma

Por Tarhini, Ahmad A., Kirkwood, John M.
Publicado em 2009

Adjuvant Therapy for Melanoma

Por Davar, Diwakar, Tarhini, Ahmad A., Kirkwood, John M.
Publicado em 2012

IFN-α in the Treatment of Melanoma

Por Tarhini, Ahmad A., Gogas, Helen, Kirkwood, John M.
Publicado no J Immunol (2012)

Immune Checkpoint Blockade and Interferon-α in Melanoma

Por Rafique, Imran, Kirkwood, John M, Tarhini, Ahmad A
Publicado no Semin Oncol (2015)

Prognostic Significance of Serum S100B Protein in High-Risk Surgically Resected Melanoma Patients Participating in Intergroup Trial ECOG 1694

Por Tarhini, Ahmad A., Stuckert, Joseph, Lee, Sandra, Sander, Cindy, Kirkwood, John M.
Publicado em 2009

Annual Hospital Volume of High Dose Interleukin-2 and Inpatient Mortality in Melanoma and Renal Cell Carcinoma Patients

Por Mehta, Kathan, Appleman, Leonard, Wang, Hong, Tarhini, Ahmad A., Parikh, Rahul A.
Publicado no PLoS One (2016)

Immunotherapy of Cancer in 2012

Por Kirkwood, John M., Butterfield, Lisa H., Tarhini, Ahmad A., Zarour, Hassane, Kalinski, Pawel, Ferrone, Soldano
Publicado em 2012

Differing Patterns of Circulating Regulatory T-Cells and Myeloid Derived Suppressor Cells in Metastatic Melanoma Patients Receiving Anti-CTLA4 Antibody and Interferon-α or TLR-9 Ag...

Por Tarhini, Ahmad A, Butterfield, Lisa H., Shuai, Yongli, Gooding, William E., Kalinski, Pawel, Kirkwood, John M
Publicado em 2012

Serologic evidence of autoimmunity in E2696 and E1694 patients with high-risk melanoma treated with adjuvant interferon alfa

Por Tarhini, Ahmad A., Shin, Donghoon, Lee, Sandra J., Stuckert, Joseph, Sander, Cindy A., Kirkwood, John M.
Publicado no Melanoma Res (2014)

Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumab

Por Retseck, Janet, VanderWeele, Robert, Lin, Hui-Min, Lin, Yan, Butterfield, Lisa H., Tarhini, Ahmad A.
Publicado no J Immunother Cancer (2016)

Melanoma antigen-specific effector T cell cytokine secretion patterns in patients treated with ipilimumab

Por Najjar, Yana G., Ding, Fei, Lin, Yan, VanderWeele, Robert, Butterfield, Lisa H., Tarhini, Ahmad A.
Publicado no J Transl Med (2017)

Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma

Por Tarhini, Ahmad A., Zahoor, Haris, Lin, Yan, Malhotra, Usha, Sander, Cindy, Butterfield, Lisa H., Kirkwood, John M.
Publicado no J Immunother Cancer (2015)

Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG)

Por Anker, Christopher J., Grossmann, Kenneth F., Atkins, Michael B., Suneja, Gita, Tarhini, Ahmad A., Kirkwood, John M.
Publicado no Int J Radiat Oncol Biol Phys (2016)

Expression profiles of immune-related genes are associated with neoadjuvant ipilimumab clinical benefit

Por Tarhini, Ahmad A., Lin, Yan, Lin, Hui-Min, Vallabhaneni, Priyanka, Sander, Cindy, LaFramboise, William, Hamieh, Lana
Publicado no Oncoimmunology (2016)

Safety and immunogenicity of vaccination with MART-1 (26-35, 27L), gp100 (209-217, 210M), and tyrosinase (368-376, 370D) in-adjuvant with PF-3512676 and GM-CSF in metastatic melano...

Por Tarhini, Ahmad A, Leng, Siyang, Moschos, Stergios J, Yin, Yan, Sander, Cindy, Lin, Yan, Gooding, William E, Kirkwood, John M
Publicado em 2012

A four-marker signature of TNF-RII, TGF-α, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanoma

Por Tarhini, Ahmad A, Lin, Yan, Yeku, Oladapo, LaFramboise, William A, Ashraf, Madeeha, Sander, Cindy, Kirkwood, John M, Lee, Sandra
Publicado em 2014

Safety and Efficacy of Combination Immunotherapy With Interferon Alfa-2b and Tremelimumab in Patients With Stage IV Melanoma

Por Tarhini, Ahmad A., Cherian, John, Moschos, Stergios J., Tawbi, Hussein A., Shuai, Yongli, Gooding, William E., Sander, Cindy, Kirkwood, John M.
Publicado em 2012

Phase I Trial of Carboplatin and Etoposide in Combination with Panobinostat in Patients with Lung Cancer

Por TARHINI, AHMAD A., ZAHOOR, HARIS, MCLAUGHLIN, BRIAN, GOODING, WILLIAM E., SCHMITZ, JOHN C., SIEGFRIED, JILL M., SOCINSKI, MARK A., ARGIRIS, ATHANASSIOS
Publicado em 2013